Related Experiment Videos
Breast-conserving radiation therapy using combined electron and intensity-modulated radiotherapy technique
J G Li1, S S Williams, D R Goffinet
1Department of Radiation Oncology, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305-5304, USA.
Summary
A new multi-modality radiation therapy technique combining electron beams and intensity-modulated photon beams can reduce radiation dose to the ipsilateral lung and heart in breast cancer patients. This approach improves upon conventional tangential field treatments.
Area of Science:
- Radiation Oncology
- Medical Physics
Background:
- Conventional breast-conserving radiation therapy often involves tangential fields, which can deliver high doses to the ipsilateral lung and heart.
- Reducing dose to these organs is crucial for minimizing treatment toxicity and long-term side effects.
Purpose of the Study:
- To assess the feasibility of a novel multi-modality breast-conserving radiation therapy technique.
- To compare the dose delivered to the ipsilateral lung and heart with this new technique versus conventional tangential fields.
Main Methods:
- A treatment plan combining an electron beam with four intensity-modulated photon beams was developed.
- An iterative algorithm optimized electron beam weight and photon beam fluence profiles.
- Two early-stage breast cancer patients underwent treatment planning with the new technique, tangential fields, and 9-field IMRT.
Main Results:
- The combined electron and IMRT technique achieved better target dose conformity and significantly reduced dose to the ipsilateral lung compared to tangential fields.
- The heart dose was also reduced in the left-breast patient.
- Doses to other normal structures were comparable to conventional plans and lower than 9-field IMRT.
Conclusions:
- The combined electron and IMRT technique is a feasible and improved approach over conventional tangential fields for breast-conserving radiation therapy.
- This technique effectively reduces radiation dose to the ipsilateral lung and heart, while minimizing dose to other critical structures.